Retatrutide 30mg GoQuick Pen 5.00 out of 5 based on 2 customer ratings 325,00 Retatrutide is a novel triple agonist peptide developed for the treatment of type 2 diabetes (T2D) and obesity
If one of these causes started around the same time you started taking a GLP-1, it could explain the changes youre experiencing
The newly approved oral GLP-1 drug works by: Reducing appetite Slowing digestion Improving blood sugar control Unlike injections, this pill offers: Easier daily use Greater accessibility Wider adoption potential This could change the entire weight loss market in 2026
Even though these changes are a sign of fat loss and improved health, they can negatively impact confidence and body image, especially if someone is not prepared for how quickly their appearance may shift
Some experience persistent nausea even at the 1mg starting dose
GLP-1 Important Safety Information: Read more about serious warnings and safety info